Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-11

Clinical Trial Update: Study of Aripiprazole in Subjects With Alcoholism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating aripiprazole for alcohol use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole) (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Alcoholism | Phase 4 | Status: COMPLETED